Contact Us
  Search
The Business Research Company Logo
Global Precision Medicine Software Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Precision Medicine Software Market Report 2026

Global Outlook – By Software Type (Clinical Decision Support Systems (CDSS), Genomic Data Analysis Tools, Data Integration And Management Software, Patient Management Software, Bioinformatics Tools), By Technology (Artificial Intelligence And Machine Learning, Big Data Analytics, Blockchain Technology, Internet of Medical Things (IoMT), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) And Gene Editing Tools), By Deployment (Cloud, On-Premise), By Application (Oncology, Central Nervous System, Immunology, Cardiovascular, Other Applications), By End User (Healthcare Providers, Research Centers And Government Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035

Precision Medicine Software Market Overview

• Precision Medicine Software market size has reached to $2.45 billion in 2025 • Expected to grow to $4.92 billion in 2030 at a compound annual growth rate (CAGR) of 14.9% • Growth Driver: Increasing Demand For Personalized Treatment Fueling The Growth Of The Market Due To Advances In Genomic Technologies • Market Trend: AI-Driven Platforms Enable Rapid Creation Of Regulated Health Applications • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Precision Medicine Software Market?

Precision medicine software refers to specialized digital platforms that analyze individual patient data, such as genetic, molecular, clinical, and lifestyle information, to tailor personalized treatment and prevention strategies. Its primary purpose is to support clinicians in making data-driven decisions that optimize therapeutic outcomes based on a person’s unique biological profile. The main types of precision medicine software include clinical decision support systems (CDSS), genomic data analysis tools, data integration and management software, patient management software, and bioinformatics tools. Clinical decision support systems are health information technology tools designed to assist healthcare professionals in making informed clinical decisions by providing evidence-based knowledge, patient-specific data, and treatment recommendations at the point of care. This system leverages various technologies such as artificial intelligence and machine learning, big data analytics, blockchain technology, the Internet of Medical Things (IoMT), and CRISPR and gene editing tools, and is deployed on both cloud and on-premise infrastructures. It is used across a wide range of applications, including oncology, central nervous system disorders, immunology, cardiovascular diseases, and others, serving end users such as healthcare providers, research centers, government institutes, pharmaceutical companies, biotechnology firms, and others.
Precision Medicine Software Market Global Report 2026 Market Report bar graph

What Is The Precision Medicine Software Market Size and Share 2026?

The precision medicine software market size has grown rapidly in recent years. It will grow from $2.45 billion in 2025 to $2.82 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to advancements in genomic sequencing technologies, expansion of electronic health record adoption, increasing use of data-driven clinical workflows, rising oncology-focused precision treatments, growing availability of bioinformatics platforms.

What Is The Precision Medicine Software Market Growth Forecast?

The precision medicine software market size is expected to see rapid growth in the next few years. It will grow to $4.92 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for personalized therapeutics, rising investments in precision oncology programs, expansion of ai-enabled healthcare analytics, growing adoption of cloud-based clinical platforms, increasing focus on outcome-based healthcare models. Major trends in the forecast period include increasing adoption of AI-driven clinical decision support, rising integration of genomic and clinical data platforms, growing use of cloud-based precision medicine software, expansion of real-time patient data analytics, enhanced focus on interoperable healthcare systems.

Global Precision Medicine Software Market Segmentation

1) By Software Type: Clinical Decision Support Systems (CDSS), Genomic Data Analysis Tools, Data Integration And Management Software, Patient Management Software, Bioinformatics Tools 2) By Technology: Artificial Intelligence And Machine Learning, Big Data Analytics, Blockchain Technology, Internet of Medical Things (IoMT), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) And Gene Editing Tools 3) By Deployment: Cloud, On-Premise 4) By Application: Oncology, Central Nervous System, Immunology, Cardiovascular, Other Applications 5) By End User: Healthcare Providers, Research Centers And Government Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Clinical Decision Support Systems (CDSS): Diagnostic Decision Support, Therapeutic Decision Support, Clinical Guidelines And Protocols, Drug-Drug Interaction Alerts, Risk Assessment Modules 2) By Genomic Data Analysis Tools: Variant Calling And Annotation Tools, Genome Alignment Software, Gene Expression Analysis, Next-Generation Sequencing (NGS) Data Analysis, Pathway Analysis Tools 3) By Data Integration And Management Software: Electronic Health Record (EHR) Integration, Laboratory Information Management Systems (LIMS), Clinical Data Warehousing, Data Cleaning And Normalization, Metadata Management 4) By Patient Management Software: Appointment Scheduling, Patient Registry Software, Care Coordination Tools, Patient Engagement Platforms, Remote Monitoring Systems 5) By Bioinformatics Tools: Sequence Analysis Software, Structural Bioinformatics Tools, Functional Genomics Platforms, Molecular Modeling And Simulation, Proteomics And Metabolomics Tools

What Is The Driver Of The Precision Medicine Software Market?

The increasing demand for personalized treatment is expected to propel the growth of the precision medicine software market going forward. Personalized treatment refers to tailoring medical care to an individual’s unique genetic makeup, lifestyle, and health history for more effective outcomes. The rising demand for personalized treatment is due to advancements in genomic technologies, which enable precise identification of genetic variations and tailored treatments for individuals. Precision medicine software aids in personalized treatment by analyzing genetic, clinical, and lifestyle data to tailor healthcare decisions. It enhances diagnostic accuracy and treatment effectiveness, supporting more targeted and efficient patient care. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing demand for personalized treatment is driving the growth of the precision medicine software industry.

Key Players In The Global Precision Medicine Software Market

Major companies operating in the precision medicine software market are Koninklijke Philips N.V., Palantir Technologies Inc., Tempus Labs Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Color Genomics Inc., NantHealth Inc., SOPHiA GENETICS SA, Aignostics GmbH, MVision AI Oy, Fabric Genomics Inc., QUIBIM S.L., Syapse Inc., PierianDx Inc., 2bPrecise LLC, SimBioSys Inc., Navignostics AG, xCures Inc., LifeOmic Holdings LLC

What Are Latest Mergers And Acquisitions In The Precision Medicine Software Market?

In January 2023, QuartzBio, a part of Precision for Medicine, a US-based bioinformatics company, acquired SolveBio Inc. for an undisclosed amount. With this acquisition, Precision for Medicine aims to enhance QuartzBio’s software as a service (SaaS) capabilities by integrating SolveBio’s enterprise data management platform, enabling streamlined clinical sample and biomarker data management across the drug development lifecycle. SolveBio Inc. is a US-based data integration and analysis company focused on delivering genomic and clinical data solutions for precision medicine.

Regional Outlook

North America was the largest region in the precision medicine software market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Precision Medicine Software Market?

The precision medicine software market consists of revenues earned by entities by providing services such as biomarker identification, patient stratification, treatment planning, data integration from electronic health records (EHRs), and laboratory information systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision medicine software market also consists of sales of clinical analytics platforms, genomic interpretation tools, bioinformatics software, and AI-driven diagnostic solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Precision Medicine Software Market Report 2026?

The precision medicine software market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine software industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Precision Medicine Software Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$2.82 billion
Revenue Forecast In 2035$4.92 billion
Growth RateCAGR of 15.1% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredSoftware Type, Technology, Deployment, Application, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledKoninklijke Philips N.V., Palantir Technologies Inc., Tempus Labs Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Color Genomics Inc., NantHealth Inc., SOPHiA GENETICS SA, Aignostics GmbH, MVision AI Oy, Fabric Genomics Inc., QUIBIM S.L., Syapse Inc., PierianDx Inc., 2bPrecise LLC, SimBioSys Inc., Navignostics AG, xCures Inc., LifeOmic Holdings LLC
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us